HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
27277studies shown
Showing 6,457-6,468 of 27,277
Device study icon
CompletedNCT00168311

Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation in the Treatment of Negative Symptoms for schizophrenia

Official study title

A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magentic Stimulation (rTMS) in the Treatment of Negative Symptoms in Schizophrenia and Related Disorders

This study has finished and is no longer accepting participants.

In Melbourne
SchizophreniaDevice studyAges 18–70
Countries
Australia
Sponsor
The Alfred
Drug study icon
CompletedNCT00376220

A Placebo Controlled study of Riluzole in Depression in bipolarity

What is this study about?

Researchers compared Riluzole and placebo to find out how the approaches affected depression symptoms in people with bipolarity during a depressive episode.

This study has finished and is no longer accepting participants.

In Baltimore
Bipolarity, DepressionMedication studyAges 18–75
Countries
United States
Sponsor
Johns Hopkins University
Drug study icon
CompletedNCT00232414

Quetiapine for depression

Official study title

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

This study has finished and is no longer accepting participants.

In Cincinnati
Bipolarity, DepressionMedication studyAges 12–18
Countries
United States
Sponsor
University of Cincinnati
Drug study icon
CompletedNCT02133001

Intranasal Esketamine for depression

What is this study about?

This study evaluated the safety and effectiveness of Esketamine for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
Depression, SuicidalityMedication studyAges 18–64
Countries
United States
Sponsor
Janssen Research & Development, LLC
Drug study icon
CompletedEUCTR 2005-004006-81

A double-blind, 6 to 12-month, multicenter, multinational, randomized study evaluating the efficacy and safety of SR58611A (350 mg q12) versus placebo in the prevention of relapse / recurrence of d...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Czech Republic
DepressionHistorical research record
Countries
Czechia, Finland, Slovakia
Sponsor
sanofi-aventis recherche&developpement
Drug study icon
CompletedEUCTR 2013-004005-11

A Double-Blind, Doubly-Randomized, Placebo-Controlled Study of Intranasal Esketamine in an Adaptive Treatment Protocol to Assess Safety and Efficacy in Treatment-Resistant Depression (SYNAPSE)

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Belgium
DepressionHistorical research record
Countries
Belgium
Sponsor
Janssen-Cilag International NV
Drug study icon
CompletedNCT00374777

A Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients

Official study title

FK199B (Zolpidem MR Tablet) Phase III Clinical Study -A Double-Blind, Placebo- and Nitrazepam-Controlled, Group-Comparison Study in Patients With Insomnia Associated With Schizophrenia and Manic-Depressive Psychosis

This study has finished and is no longer accepting participants.

Multiple locations, including Chubu Region
BipolarityMedication studyAges 20–64
Countries
Japan
Sponsor
Astellas Pharma Inc
Drug study icon
CompletedNCT00140426

A Placebo Controlled study of Risperidone for Eating disorders

Official study title

A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia Nervosa

This study has finished and is no longer accepting participants.

In Denver
Eating disordersMedication studyAges 12–21
Countries
United States
Sponsor
University of Colorado, Denver

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.